ATE516039T1 - Ersatz einer herzoperation durch mikronährstoff - Google Patents

Ersatz einer herzoperation durch mikronährstoff

Info

Publication number: ATE516039T1
Authority: AT; Austria
Prior art keywords: micronutrient; heart surgery; replacement; disclosed; composition
Prior art date: 2006-08-14

Application number

AT07734535T

Other languages

English (en)

Inventor

Hayat Azmat

Mamoona Bibi

Bibi Shahnaz

Original Assignee

Bibi Shahnaz

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-14

Filing date

2007-05-08

Publication date

2011-07-15

2007-05-08 Application filed by Bibi Shahnaz filed Critical Bibi Shahnaz

2007-05-08 Priority claimed from PCT/IB2007/001225 external-priority patent/WO2008020275A1/en

2011-07-15 Application granted granted Critical

2011-07-15 Publication of ATE516039T1 publication Critical patent/ATE516039T1/de

Links

239000011785 micronutrient Substances 0.000 title abstract 2
235000013369 micronutrients Nutrition 0.000 title abstract 2
238000001356 surgical procedure Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 3
240000000111 Saccharum officinarum Species 0.000 abstract 1
235000007201 Saccharum officinarum Nutrition 0.000 abstract 1
ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 abstract 1
229910000366 copper(II) sulfate Inorganic materials 0.000 abstract 1
235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
208000019622 heart disease Diseases 0.000 abstract 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 abstract 1
229910000359 iron(II) sulfate Inorganic materials 0.000 abstract 1
SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 abstract 1
229910000357 manganese(II) sulfate Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Materials For Medical Uses (AREA)
Medicinal Preparation (AREA)

AT07734535T 2006-08-14 2007-05-08 Ersatz einer herzoperation durch mikronährstoff ATE516039T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0616201A GB2440909B (en)	2006-08-14	2006-08-14	Micronutrient composition suitable for treating heart diseases
PCT/IB2007/001225 WO2008020275A1 (en)	2006-08-14	2007-05-08	Replacing heart surgery by micronutrient

Publications (1)

Publication Number	Publication Date
ATE516039T1 true ATE516039T1 (de)	2011-07-15

Family

ID=37081015

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07734535T ATE516039T1 (de)	2006-08-14	2007-05-08	Ersatz einer herzoperation durch mikronährstoff

Country Status (3)

Country	Link
CN (1)	CN101528241A (de)
AT (1)	ATE516039T1 (de)
GB (1)	GB2440909B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE790231L (en) *	1978-02-08	1979-08-08	Michael Anthony Neaverson	Compositions suitable for the treatment of heat exhaustion
JP3484689B2 (ja) *	1998-12-18	2004-01-06	ニプロ株式会社	微量元素製剤
JP2005035962A (ja) *	2003-07-18	2005-02-10	Otsuka Pharmaceut Factory Inc	鉄配合輸液製剤
AU2005237315B2 (en) *	2004-05-03	2009-10-08	Virbac (Australia) Pty Ltd	Trace elements

2006
- 2006-08-14 GB GB0616201A patent/GB2440909B/en active Active
2007
- 2007-05-08 AT AT07734535T patent/ATE516039T1/de not_active IP Right Cessation
- 2007-05-08 CN CNA2007800383223A patent/CN101528241A/zh active Pending

Also Published As

Publication number	Publication date
GB2440909B (en)	2009-08-19
CN101528241A (zh)	2009-09-09
GB2440909A (en)	2008-02-20
GB0616201D0 (en)	2006-09-27

Similar Documents

Publication	Publication Date	Title
EA201101187A1 (ru)	2012-10-30	Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EA201101189A1 (ru)	2012-03-30	Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
DOP2007000102A (es)	2007-12-31	Arilimidazolonas y ariltriazolona sustituidas asi como su uso
EA201000515A1 (ru)	2010-10-29	Активаторы глюкокиназы
MX2009005935A (es)	2009-06-30	Compuestos biciclicos y su uso como anti-diabeticos.
KZ24152B (en)	2011-06-15	Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
EA201300522A1 (ru)	2013-11-29	Фармацевтические комбинации для лечения метаболических нарушений
EA201000984A1 (ru)	2011-02-28	Синтетические тритерпеноиды и способы их применения в лечении заболеваний
DE602006007093D1 (de)	2009-07-16	Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
EA201101117A1 (ru)	2012-03-30	Ингибиторы дпп-4 для лечения диабета у детей
EA201300550A1 (ru)	2014-02-28	Фармацевтическая композиция, способы лечения и их применение
EA200900177A1 (ru)	2009-06-30	Замещенные ациланилиды и способы их применения
WO2007124461A3 (en)	2008-06-05	Glp-1 compounds
EA201000559A1 (ru)	2010-10-29	Композиции и способы применения антител к склеростину
WO2010049678A3 (en)	2010-08-26	Treatment of energy utilization diseases
MX2010007038A (es)	2010-10-15	Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
MX2009011359A (es)	2009-11-05	Derivados de pirimidinona y sus metodos de uso.
EA200802184A1 (ru)	2009-06-30	Фармацевтические композиции с ингибиторами dpp iv
BRPI0814737A2 (pt)	2015-03-03	Composição, métodos para reduzir, retardar ou de um outro modo inibir o crescimento e/ou replicação de hcv, para prevenir a infecção de uma célula exposta a hcv, para tratar terapeuticamente ou profilaticamente um paciente exposto ou infectado com hcv, e para tratar hepatite c, e, uso de uma composição.
MX2011011670A (es)	2011-11-18	Inmunoglobulinas de dominio variable dual y usos de las mismas.
EA201100302A1 (ru)	2011-10-31	Лечение диабета у пациентов, для которых лечение метформином является неприемлемым
WO2008008887A3 (en)	2008-04-17	Gpr119 agonists for treating metabolic disorders
WO2007143098A8 (en)	2009-01-08	Hepatocyte growth factor (hgf) binding proteins
EA201100621A1 (ru)	2011-12-30	Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
MY170570A (en)	2019-08-19	Human antibodies to the human glucagon receptor and methods of use thereof

Legal Events

Date	Code	Title	Description
2012-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties